Predictive and prognostic potential of pretreatment 68Ga-PSMA PET tumor heterogeneity index in patients with metastatic castration-resistant prostate cancer (mCRPC).

Authors

null

Majid Assadi

Bushehr University of Medical Sciences, Bushehr, Iran (Islamic Republic of)

Majid Assadi , Reyhaneh Manafi-Farid , Esmail Jafai , Ahmad Keshavarz , GhasemAli Divband , Mohammad Mobin Moradi , Zohreh Adinehpour , Rezvan Samimi , Habibollah Dadgar , Benjamin Mayer , Vikas Prasad

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 200)

DOI

10.1200/JCO.2023.41.6_suppl.200

Abstract #

200

Poster Bd #

F6

Abstract Disclosures

Similar Posters

Poster

2020 Genitourinary Cancers Symposium

Prognostic value of novel inflammation index for patients with metastatic castration-resistant prostate cancer.

Prognostic value of novel inflammation index for patients with metastatic castration-resistant prostate cancer.

First Author: Yasutaka Yamada

First Author: Peter C.C. Fong

First Author: Eli Tran